These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 23142123

  • 1. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ, Fowler AJ, Paquette KM, Richer AL, Tran N, Bremner RM.
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
    Shor AC, Keschman EA, Lee FY, Muro-Cacho C, Letson GD, Trent JC, Pledger WJ, Jove R.
    Cancer Res; 2007 Mar 15; 67(6):2800-8. PubMed ID: 17363602
    [Abstract] [Full Text] [Related]

  • 7. New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization.
    Indovina P, Giorgi F, Rizzo V, Khadang B, Schenone S, Di Marzo D, Forte IM, Tomei V, Mattioli E, D'Urso V, Grilli B, Botta M, Giordano A, Pentimalli F.
    Oncogene; 2012 Feb 16; 31(7):929-38. PubMed ID: 21785466
    [Abstract] [Full Text] [Related]

  • 8. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
    Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB.
    Cancer Res; 2006 Jun 01; 66(11):5542-8. PubMed ID: 16740687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D, Fléjou JF.
    Virchows Arch; 2003 Jan 01; 442(1):18-24. PubMed ID: 12536310
    [Abstract] [Full Text] [Related]

  • 12. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK.
    Cancer Epidemiol Biomarkers Prev; 2008 Jun 01; 17(6):1380-5. PubMed ID: 18559552
    [Abstract] [Full Text] [Related]

  • 13. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP, Lee EL, Shay JW.
    Cancer; 1998 Aug 15; 83(4):652-9. PubMed ID: 9708927
    [Abstract] [Full Text] [Related]

  • 14. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS, Shekelle PG, Jensen DM, Spiegel BM, Chen J, Oh D, Kahn KL.
    Am J Gastroenterol; 2005 Apr 15; 100(4):775-83. PubMed ID: 15784018
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD, Buckles D, Al-Kasspooles M.
    Expert Rev Anticancer Ther; 2009 Mar 15; 9(3):303-16. PubMed ID: 19275509
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
    Soslow RA, Remotti H, Baergen RN, Altorki NK.
    Mod Pathol; 1999 Mar 15; 12(3):239-50. PubMed ID: 10102608
    [Abstract] [Full Text] [Related]

  • 20. Genomic alterations in malignant transformation of Barrett's esophagus.
    Riegman PH, Vissers KJ, Alers JC, Geelen E, Hop WC, Tilanus HW, van Dekken H.
    Cancer Res; 2001 Apr 01; 61(7):3164-70. PubMed ID: 11306503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.